Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2002;99:795-798
© 2002 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nyman, M.
Right arrow Articles by Broliden, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nyman, M.
Right arrow Articles by Broliden, K.

ORIGINAL RESEARCH

Detection of Human Parvovirus B19 Infection in First-Trimester Fetal Loss

Margareta Nyman, MD, PhD, Thomas Tolfvenstam, MD, PhD, Karin Petersson, MD, Christina Krassny, MD, Lottie Skjöldebrand-Sparre, MD, PhD and Kristina Broliden, MD, PhD

From the Division of Obstetrics and Gynecology, Karolinska Institutet, Danderyd Hospital, Danderyd, Sweden; and Departments of Clinical Virology and Obstetrics and Gynecology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden.

Address reprint requests to: Kristina Broliden, MD, PhD, Karolinska Institutet, Huddinge University Hospital, Department of Clinical Virology, F68, Stockholm, S-141 86, Sweden; E-mail: kristina.broliden{at}viruslab.hs.sll.se.

OBJECTIVE: To investigate the frequency of parvovirus B19 infection in first-trimester fetal loss, as measured by B19 DNA polymerase chain reaction in placental tissue in a prospective descriptive study from a nonendemic area.

METHODS: Placental tissues from first-trimester fetal losses were examined for presence of B19 DNA by polymerase chain reaction in a prospective study during 30 months. For comparison, placental tissues from second-trimester fetal losses, as well as from full-term normal pregnancies, were also studied.

RESULTS: B19 DNA was detected by polymerase chain reaction in one of 36 (3%) placental tissues from first-trimester fetal losses. In second-trimester fetal losses, eight of 64 (12%) samples were B19 DNA positive. None of the 53 placental tissues from full-term normal pregnancies were B19 DNA positive. In first-trimester fetal losses, maternal serum from the B19 DNA-positive sample was B19 immunoglobulin (Ig)G positive but B19 IgM negative. In second-trimester fetal losses, six of six tested B19 DNA-positive samples were both B19 IgG and IgM positive.

CONCLUSION: The frequency of first-trimester fetal loss associated with parvovirus B19 infection was low, 3%, during a nonepidemic period in Sweden, as measured by B19 DNA-specific polymerase chain reaction in placental tissue.




This article has been cited by other articles:


Home page
Obstet GynecolHome page
M. S. Amstey and K. Broliden
Detection of Human Parvovirus B19 Infection in First-Trimester Fetal Loss
Obstet. Gynecol., October 1, 2002; 100(4): 831 - 832.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American College of Obstetricians and Gynecologists.